Changes in brachial-ankle pulse wave velocity in subclinical hypothyroidism during normalization of thyroid function

Biomedicine and Pharmacotherapy

Volumn 61, Issue 8, 2007, Pages 482-487

  Nagasaki, Toshiki ^a   Inaba, Masaaki ^a   Yamada, Shinsuke ^a   Kumeda, Yasuro ^a   Hiura, Yoshikazu ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Arterial stiffening; Brachial ankle pulse wave velocity; Levothyroxine; Subclinical hypothyroidism

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVOTHYROXINE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BRACHIAL ANKLE PULSE WAVE VELOCITY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; GENDER; HUMAN; HYPOTHYROIDISM; JAPAN; MALE; MEASUREMENT; PARAMETER; PREDICTION; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; SEX DIFFERENCE; THYROID FUNCTION;

AGED; ANKLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULSE; SEX FACTORS; THYROXINE;

EID: 34548535810     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.04.004     Document Type: Article

References (31)

1. Evered D.C., Tunbridge W.M., Hall R., Appleton D., Brewis M., Clark F., et al. Thyroid hormone concentrations in a large scale community survey. Effect of age, sex, illness and medication. Clin Chim Acta 83 (1978) 223-229
2. Hak A.E., Pols H.A., Visser T.J., Drexhage H.A., Hofman A., and Witteman J.C. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132 (2000) 270-278
3. Imaizumi M., Akahoshi M., Ichimaru S., Nakashima E., Hida A., Soda M., et al. The endocrine society risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 89 (2004) 3365-3370
4. Luboshitzky R., Aviv A., Herer P., and Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12 (2002) 421-425
5. Althaus B.U., Staub J.J., Ryff-De Leche A., Oberhansli A., and Stahelin H.B. 1998 LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol 28 (1998) 157-163
6. Pearce E.N. Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr Cardiol Rep 6 (2004) 451-456
7. Monzani F., Caraccio N., Kozakowa M., Dardano A., Vittone F., Virdis A., et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab 89 (2004) 2099-2106
8. Monzani F, Di Bello V, Caraccio N, Bertini A, Giorgi D, Giusti C, et al. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 2001;86:1110-15.
9. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25 (2002) 359-364
10. Measume S., Benetos A., Henry O.F., Rundnichi A., and Safar M.E. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 21 (2001) 2046-2050
11. Nagasaki T., Inaba M., Kumeda Y., Hiura Y., Shirakawa K., Yamada S., et al. Increased brachial-ankle pulse wave velocity in subclinical hypothyroid patients. J Clin Endocrinol Metab 91 (2006) 154-158
12. Takami T., and Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 26 (2003) 609-614
13. Miura S., Tanaka E., Mori A., Toya M., Takahashi K., Nakahara K., et al. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women. Maturitas 45 (2003) 293-298
14. Christofides N.D., and Sheehan C.D. Enhanced chemiluminescence labeled-antibody immunoassay (Amerlite-MAB) for free thyroxine: design, development, and technical validation. Clin Chem 41 (1995) 17-23
15. Kelly R., Hayward C., Avolio A., and O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation 80 (1989) 1652-1659
16. Li B., Gao H., Li X., Liu Y., and Wang M. Correlation between brachial-ankle pulse wave velocity and arterial compliance and cardiovascular risk factors in elderly patients with arteriosclerosis. Hypertens Res 29 (2006) 309-314
17. Andoh N., Minami J., Ishimitsu T., Ohrui M., and Matsuoka H. Relationship between markers of inflammation and brachial-ankle pulse wave velocity in Japanese men. Int Heart J 47 (2006) 409-420
18. Owen P.J.D., and Lazarus J.H. Subclinical hypothyroidism: the case for treatment. Trends Endocrinol Metab 14 (2003) 257-261
19. Meier C., Staub J.J., Roth C.B., Gueglielmetti M., Kunz M., Miserez A.R., et al. TSH controlled L-thyroxine therapy reduces cholesterol levels. J Clin Endocrinol Metab 86 (2001) 4860-4866
20. Nystrom E., Caidahl K., Fager G., Wikkelso C., Lundberg P.A., and Lindstedt G. A double blind cross over 12 month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. J Clin Endocrinol Metab 29 (1988) 63-75
21. Cooper D.S., Halpern R., Wood L.C., Levin A.A., and Ridgway E.C. L-Thyroxine therapy in subclinical hypothyroidism. A double blind, placebo-controlled trial. Ann Intern Med 101 (1984) 18-24
22. Kahaly G.J. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10 (2000) 665-679
23. Biondi B., and Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24 (2004) 1-13
24. Tomiyama H., Yamashina A., Arai T., Hirose K., Koji Y., Chikamori T., et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement-a survey of 12517 subjects. Atherosclerosis 166 (2003) 303-309
25. Hueston W.J., and Pearson W.S. Subclinical hypothyroidism and the risk of hypercholesterolaemia. Ann Fam Med 2 (2004) 351-355
26. Weissel M. Possible consequences of subclinical hypothyroidism. Acta Med Austriaca 30 (2003) 93-97
27. Ohnishi H., Saitoh S., Takagi S., Ohata J., Isobe T., Kikuchi Y., et al. Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose: the Tanno and Sobetsu study. Diabetes Care 26 (2003) 437-440
28. Kim J.S., Kang T.S., Kim J.B., Seo H.S., Park S., Kim C., et al. Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertensive patients. Atherosclerosis (2006) Epub ahead of print
29. Nagano M., Nakamura M., Sato K., Tanaka F., Segawa T., and Hiramori K. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis 180 (2005) 189-195
30. Obuobie K., Smith J., Evans L.M., John R., Davies J.S., and Lazarus J.H. Increased central arterial stiffness in hypothyroidism. J Clin Endocrinol Metab 87 (2002) 4662-4666
31. Shinohara K., Shoji T., Kimoto E., Yokoyama H., Fujiwara S., Hatsuda S., et al. Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus. J Atheroscler Thromb 12 (2005) 205-210